<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestomm</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник охраны материнства и младенчества</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of maternal and child care</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">3034-395X</issn><publisher><publisher-name>ФГБУ «НИИ ОММ» Минздрава России</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.69964/BMCC-2024-1-1-86-94</article-id><article-id custom-type="elpub" pub-id-type="custom">vestomm-12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Клинические особенности желудочно-кишечных симптомов у женщин с рецидивирующим течением глубокого инфильтративного эндометриоза</article-title><trans-title-group xml:lang="en"><trans-title>Clinical features of gastrointestinal symptoms in women with recurrent course of deep infiltrative endometriosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-6127-6957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Браславская</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Braslavskaya</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Браславская Елена Павловна — врач акушер-гинеколог отделения сохранения репродуктивной функции.</p><p>ул. Репина, д. 1, Екатеринбург, 620028</p><p>Телефон: +7-922-213-26</p></bio><bio xml:lang="en"><p>Elena P. Braslavskaya — obstetrician-gynecologist of Department of reproductive functions preservation, Federal State Budgetary Institution “Ural Research Institute of Maternity and Child Care” of the Ministry of Health of the Russian Federation.</p><p>Repina st., 1, Ekaterinburg, 620028</p><p>Phone: +7-922-213-26-91</p></bio><email xlink:type="simple">lenabraslavskaya1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4090-0578</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мелкозерова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Melkozerova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мелкозерова Оксана Александровна — доктор медицинских наук, доцент, заместитель директора института по науке.</p><p>ул. Репина, д. 1, Екатеринбург, 620028</p><p>Телефон: +7 (343)-371-24-27, +7-922-219-45-06</p></bio><bio xml:lang="en"><p>Oksana A. Melkozerova — МD, docent, Deputy of Director for Science, Federal State Budgetary Institution “Ural Research Institute of Maternity and Child Care” of the Ministry of Health of the Russian Federation.</p><p>Repina st., 1, Ekaterinburg, 620028</p><p>Phone: +7 (343)-371-24-27, +7-922-219-45-06</p></bio><email xlink:type="simple">abolmed1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3855-3650</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенов</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenov</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенов Юрий Алексеевич — доктор медицинских наук, Заслуженный врач Российской Федерации, директор.</p><p>ул. Репина, д. 1, Екатеринбург, 620028</p><p>Телефон: + 7 (343) 371 87 68</p></bio><bio xml:lang="en"><p>Yuri A. Semenov — Doctor of Medical Sciences, Honored Doctor of the Russian Federation, Director of the Federal State Budgetary Institution “Ural Research Institute of Maternity and Child Care” of the Ministry of Health of the Russian Federation.</p><p>Repina st., 1, Ekaterinburg, 620028</p><p>Phone: + 7 (343) 371 87 68</p></bio><email xlink:type="simple">u-sirius@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1709-6187</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михельсон</surname><given-names>А. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhelson</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михельсон Анна Алексеевна — доктор медицинских наук, доцент, руководитель отделения сохранения репродуктивной функции заведующая отделением гинекологии.</p><p>ул. Репина, д. 1, Екатеринбург, 620028</p><p>Телефон: +7 (343) 371-24-27</p></bio><bio xml:lang="en"><p>Anna A. Mikhelson — MD, docent, Head of department reproductive functions preservation, Head of the Department of Gynecology of Federal State Budgetary Institution “Ural Research Institute of Maternity and Child Care” of the Ministry of Health of the Russian Federation.</p><p>Repina st., 1, Ekaterinburg, 620028</p><p>Phone: +7 (343) 371-24-27</p></bio><email xlink:type="simple">ann_tolmik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное учреждение «Уральский научно-исследовательский институт охраны материнства и младенчества» Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Federal State Budgetary Institution “Ural Research Institute of Maternity and Child Care” of the Ministry of Health of the Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>09</month><year>2024</year></pub-date><volume>1</volume><issue>1</issue><fpage>86</fpage><lpage>94</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Браславская Е.П., Мелкозерова О.А., Семенов Ю.А., Михельсон А.A., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Браславская Е.П., Мелкозерова О.А., Семенов Ю.А., Михельсон А.A.</copyright-holder><copyright-holder xml:lang="en">Braslavskaya E.P., Melkozerova O.A., Semenov Y.A., Mikhelson A.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vestnikomm.ru/jour/article/view/12">https://www.vestnikomm.ru/jour/article/view/12</self-uri><abstract><sec><title>Введение</title><p>Введение. Эндометриоз является хроническим многофакторным заболеванием, которое поражает более 170 миллионов женщин репродуктивного возраста во всем мире, вызывая синдром тазовой боли, диспареунию, симптомы желудочно-кишечной диспепсии, тем самым оказывая отрицательное влияние на психоэмоциональное состояние пациенток. Несмотря на широкий спектр лекарственных и хирургических методов лечения, частота рецидивов достигает 50%, что является глобальной экономической и социальной проблемой. Цель исследования. Определить спектр клинических особенностей желудочно-кишечного тракта у женщин с рецидивирующим течением глубокого инфильтративного эндометриоза.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включено 113 пациенток репродуктивного возраста, которым было проведено хирургическое лечение распространенных форм наружного генитального эндометриоза. Основную группу составили 32 пациентки, перенесшие повторное оперативное лечение, в связи с рецидивом глубокого инфильтративного эндометриоза, группу сравнения — 51 пациентка без рецидива заболевания через один год после первичной операции, контрольную группу — 30 пациенток репродуктивного возраста, не страдающие наружным генитальным эндометриозом. Проведен анализ соматического анамнеза, а также, данных анкетирования о тазовой боли по визуально-аналоговой шкале (ВАШ) и функциональных расстройствах кишечника у пациенток с глубоким инфильтративным эндометриозом в зависимости от статуса рецидива заболевания.</p></sec><sec><title>Результаты исследования</title><p>Результаты исследования. Пациентки основной группы значимо чаще страдали функциональными заболеваниями желудочно-кишечного тракта (71,9% (23/32) против 51,3% (26/51) в группе сравнения; р=0,006, спектр которых был представлен хроническим гастритом и синдромом раздраженного кишечника. В основной группе клинические проявления желудочно-кишечной диспепсии до оперативного лечения соответствуют умеренно тяжелой степени 17,706 (4,601) баллов. Установлен значимо более высокий исходный уровень функциональных кишечных расстройств при субъективной оценке в основной группе наблюдения 17,706 (4,601) баллов против 10,66 (3,61) баллов в группе сравнения; р=0,001. У женщин основной группы наблюдения через один месяц после хирургического лечения отмечалось значимое снижение показателей субъективной оценки тяжести функциональных расстройств кишечника (с 17,71(4,60) баллов до 9,86 (4,73) баллов; р=0,001). Интегральный показатель ВАШ боли в основной группе составил 6,65 (1,53) баллов, что значительно выше, чем у пациенток в группе сравнения без рецидива заболевания.</p></sec><sec><title>Заключение</title><p>Заключение. Выявленные клинико-анамнестические предикторы рецидивирующего течения глубокого инфильтративного эндометриоза позволят сформировать персонифицированный подход на до- и послеоперационном этапе, направленный на профилактику рецидива заболевания, что непосредственно улучшит психоэмоциональное состояние и качество жизни женщин</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Endometriosis is a chronic multifactorial disease that aﬀects more than 170 million women of reproductive age worldwide, causing pelvic pain syndrome, dyspareunia, and symptoms of gastrointestinal dyspepsia, thereby having a negative impact on the psycho-emotional state of patients. Despite a wide range of medical and surgical treatments, the relapse rate reaches 50%, which is a global economic and social problem.</p></sec><sec><title>The purpose of the study</title><p>The purpose of the study. To determine the spectrum of clinical features of the gastrointestinal tract in women with recurrent deep infiltrative endometriosis.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study included 113 patients of reproductive age who underwent surgical treatment of common forms of external genital endometriosis. The main group consisted of 32 patients who underwent repeated surgical treatment due to relapse of deep infiltrative endometriosis, the comparison group — 51 patients without relapse of the disease one year after the primary operation, the control group — 30 patients of reproductive age who did not suﬀer from external genital endometriosis. An analysis of the somatic anamnesis was carried out, as well as questionnaire data on pelvic pain on a visual analogue scale (VAS) and functional bowel disorders in patients with deep infiltrating endometriosis, depending on the status of relapse of the disease.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Patients of the main group suﬀered significantly more often from functional diseases of the gastrointestinal tract (71.9% (23/32) versus 51.3% (26/51) in the comparison group; p = 0.006, the spectrum of which was represented by chronic gastritis and irritable bowel syndrome. In the main group, the clinical manifestations of gastrointestinal dyspepsia before surgical treatment correspond to a moderately severe degree of 17.706 (4.601) points. A significantly higher initial level of functional intestinal disorders was established during subjective assessment in the main observation group: 17.706 (4.601) points versus 10.66 (3.61) points in the comparison group; p=0.001. In women of the main observation group, one month after surgical treatment, there was a significant decrease in subjective assessment of the severity of functional intestinal disorders (from 17.71 (4.60) points to 9.86 (4.73) points; p = 0.001). The integral VAS pain score in the main group was 6.65 (1.53) points, which is significantly higher than in patients in the comparison group without relapse of the disease.</p></sec><sec><title>Conclusions</title><p>Conclusions. The identified clinical and anamnestic predictors of the recurrent course of deep infiltrative endometriosis will allow us to formulate a personalized approach at the pre- and postoperative stage, aimed at preventing relapse of the disease, which will directly improve the psycho-emotional state and quality of life of women.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>боль</kwd><kwd>глубокий инфильтративный эндометриоз</kwd><kwd>рецидив заболевания</kwd><kwd>синдром раздраженного кишечника</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pain</kwd><kwd>deep infiltrative endometriosis</kwd><kwd>disease relapse</kwd><kwd>irritable bowel syndrome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019. 1;40(4):1048-1079. https://doi:10.1210/er.2018-00242</mixed-citation><mixed-citation xml:lang="en">Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019. 1;40(4):1048-1079. https://doi:10.1210/er.2018-00242</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sarria-Santamera A. et al. Systematic review and meta-analysis of incidence and prevalence of endometriosis. Healthcare. MDPI, 2020; 9 (1):29. https://doi:10.3390/healthcare9010029</mixed-citation><mixed-citation xml:lang="en">Sarria-Santamera A. et al. Systematic review and meta-analysis of incidence and prevalence of endometriosis. Healthcare. MDPI, 2020; 9 (1):29. https://doi:10.3390/healthcare9010029</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Levy AR, Osenenko KM, Lozano-Ortega G, Sambrook R, Jeddi M, Bélisle S, Reid RL. Economic burden of surgically confirmed endometriosis in Canada. Journal of Obstetrics and Gynaecology Canada. 2011; 33(8):830-837. https://doi.org/10.1016/S1701-2163(16)34986-6</mixed-citation><mixed-citation xml:lang="en">Levy AR, Osenenko KM, Lozano-Ortega G, Sambrook R, Jeddi M, Bélisle S, Reid RL. Economic burden of surgically confirmed endometriosis in Canada. Journal of Obstetrics and Gynaecology Canada. 2011; 33(8):830-837. https://doi.org/10.1016/S1701-2163(16)34986-6</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Berlanda N., Vercellini P., Fedele L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Current Opinion in Obstetrics and Gynecology.2010;22(4):320-325. https://doi.org/10.1097/gco.0b013e32833bea15</mixed-citation><mixed-citation xml:lang="en">Berlanda N., Vercellini P., Fedele L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Current Opinion in Obstetrics and Gynecology.2010;22(4):320-325. https://doi.org/10.1097/gco.0b013e32833bea15</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Чернуха Г. Е., Ильина Л. М., Адамян Л. В., Павлович С.В. Глубокий инфильтративный эндометриоз: послеоперационные рецидивы и возможные пути их профилактики. Акушерство и гинекология. 2015; 8: 39-46.</mixed-citation><mixed-citation xml:lang="en">Chernukha G. E., Ilyina L. M., Adamyan L. V., Pavlovich S.V. Deep infiltrative endometriosis: postoperative relapses and possible ways to prevent them. Obstetrics and Gynecology. 2015;8:39-46. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor H. S., Kotlyar A. M., Flores V. A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.The Lancet. 2021;397(10276):839-852. https://doi:10.1016/S0140-6736(21)00389-5</mixed-citation><mixed-citation xml:lang="en">Taylor H. S., Kotlyar A. M., Flores V. A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.The Lancet. 2021;397(10276):839-852. https://doi:10.1016/S0140-6736(21)00389-5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Peters M, Mikeltadze I, Karro H, Saare M; Estonian Biobank Research Team; Salumets A, Mägi R, Laisk T. Endometriosis and irritable bowel syndrome: similarities and diﬀerences in the spectrum of comorbidities. Human Reproduction.2022;37(9): 2186-2196. https://doi:10.1093/humrep/deac140</mixed-citation><mixed-citation xml:lang="en">Peters M, Mikeltadze I, Karro H, Saare M; Estonian Biobank Research Team; Salumets A, Mägi R, Laisk T. Endometriosis and irritable bowel syndrome: similarities and diﬀerences in the spectrum of comorbidities. Human Reproduction.2022;37(9): 2186-2196. https://doi:10.1093/humrep/deac140</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chiaﬀarino F, Cipriani S, Ricci E, Mauri PA, Esposito G, Barretta M, Vercellini P, Parazzini F. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis.Archives of gynecology and obstetrics. 2021; 303:17-25. https://doi.org/10.1007/s00404-020-05797-8</mixed-citation><mixed-citation xml:lang="en">Chiaﬀarino F, Cipriani S, Ricci E, Mauri PA, Esposito G, Barretta M, Vercellini P, Parazzini F. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis.Archives of gynecology and obstetrics. 2021; 303:17-25. https://doi.org/10.1007/s00404-020-05797-8</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ford AC, Sperber AD, Corsetti M, Camilleri M. Functional gastrointestinal disorders 2 irritable bowel syndrome. Lancet. 2020; 396(10263):1675-1688. https://doi.org/10.1016/S0140-6736(20)31548-8</mixed-citation><mixed-citation xml:lang="en">Ford AC, Sperber AD, Corsetti M, Camilleri M. Functional gastrointestinal disorders 2 irritable bowel syndrome. Lancet. 2020; 396(10263):1675-1688. https://doi.org/10.1016/S0140-6736(20)31548-8</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet. Australian and New Zealand Journal of Obstetrics and Gynaecology.2017;57(2):201-205. https://doi.org/10.1097/01.ogx.0000521120.13781.58</mixed-citation><mixed-citation xml:lang="en">Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet. Australian and New Zealand Journal of Obstetrics and Gynaecology.2017;57(2):201-205. https://doi.org/10.1097/01.ogx.0000521120.13781.58</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Шептулин А.А., Полуэктова Е.А., Рейхарт Д.В., Белостоцкий А.В., Дроздова А.А., Арнаутов В.С. Возможности применения Опросника «7х7»(7 симптомов за 7 дней) для оценки динамики симптомов функциональной диспепсии и синдрома раздраженного кишечника. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26(3):24-33. https://doi.org/10.22416/1382-4376-2016-26-3-24-33</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Sheptulin A.A., Poluektova E.A., Reichart D.V., Belostotsky A.V., Drozdova A.A., Arnautov V.S. Possibilities of using the “7x7” Questionnaire (7 symptoms in 7 days) to assess the dynamics of symptoms of functional dyspepsia and irritable bowel syndrome. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26(3):24-33. (In Russ.) https://doi.org/10.22416/1382-4376-2016-26-3-24-33</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yang F, Wu Y, Hockey R; International Endometriosis Genetics Consortium; Doust J, Mishra GD, Montgomery GW, Mortlock S. Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management. Cell Reports Medicine.2023;4:11. https://doi.org/10.1016/j.xcrm.2023.101250</mixed-citation><mixed-citation xml:lang="en">Yang F, Wu Y, Hockey R; International Endometriosis Genetics Consortium; Doust J, Mishra GD, Montgomery GW, Mortlock S. Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management. Cell Reports Medicine.2023;4:11. https://doi.org/10.1016/j.xcrm.2023.101250</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Y, Li Y, Zhang Q, Song Y, Wang L, Zhu Z. Interactions between intestinal microbiota and neural mitochondria: A new perspective on communicating pathway from gut to brain. Frontiers in Microbiology. 2022;13:798917. https://doi.org/10.3389/fmicb.2022.798917</mixed-citation><mixed-citation xml:lang="en">Zhu Y, Li Y, Zhang Q, Song Y, Wang L, Zhu Z. Interactions between intestinal microbiota and neural mitochondria: A new perspective on communicating pathway from gut to brain. Frontiers in Microbiology. 2022;13:798917. https://doi.org/10.3389/fmicb.2022.798917</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, Bush D, Kiesel L, Tamimi R, Sharpe-Timms KL, Rombauts L, Giudice LC. World Endometriosis Society consensus on the classification of endometriosis. Human reproduction. 2017; 32(2): 315-324. https://doi.org/10.1093/humrep/dew293</mixed-citation><mixed-citation xml:lang="en">Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, Bush D, Kiesel L, Tamimi R, Sharpe-Timms KL, Rombauts L, Giudice LC. World Endometriosis Society consensus on the classification of endometriosis. Human reproduction. 2017; 32(2): 315-324. https://doi.org/10.1093/humrep/dew293</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
